Changes of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Gene Level in the Hippocampus of Experimental Alzheimer’s Disease Mice

Abstract

Abstract:Objective: To investigate the dynamic alteration of PTEN（Phosphatase and Tensin Homolog Deleted on Chromosome 10）and phospho-PTEN levels at different stages of mimic Alzheimer’s disease（AD）mice induced by AlCl3.Methods：AD-like mouse was made by intracere-broventricular injection（icv）of 2 μL of 0.5% AlCl₃dissolved in artificial cerebrospinal fluid, once a day, consecutively for 5 d. Passive avoidance response test was used at d 2 and d 7, and Morris water maze test at d 23 to d 30 after the last icv injection to detect the learning and memory capabilities of mice. Western Blotting was used to detect the protein levels of PTEN and phospho-PTEN in the hippocampus of mice.Results: The results of step through passive avoidance response showed a significant retardation of the model mice from d 2 to d 7 after the last icv injection compared with that of the control group; from d 23 to d 30 after the last icv injection, Morris water maze（MWM） performance displayed a significant impairment in learning and memory ability of model mice. No significant differences on protein levels of PTEN and phospho-PTEN in the hippocampus were found between the model mice and control mice at the d 2 and d 7 time-points after the last icv injection. At the d 30 time-point after the last icv injection, the protein level of phospho-PTEN-Ser³⁸⁰of the model mice was significantly lower than that of the control group, but no significant difference about PTEN protein level.Conclusion：The phospho-PTEN protein level of hippocampus in the late development stage of mimic AD mice induced by aluminum toxicity is decreased significantly.

Key words:Alzheimer&,rsquo,s disease,PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) phospho-PTEN,hippocampus,mice,learning and memory

CLC Number:

R749.16

XU Jian-wen, YANG Jian, YU Chang-xi. Changes of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Gene Level in the Hippocampus of Experimental Alzheimer’s Disease Mice[J]. Acta Neuropharmacologica, 2011, 1(2): 19-23.

References

1. Alonzo H.Ross, Arne Gericke. Phosphorylation keeps PTEN phosphatase closed for business [J].Proc Natl Acad Sci USA, 2009, 106(5):1297-1298.
2. Lia Baki, Junichi Shioi, Paul Wen,et al. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutation [J]. EMBO J,2004, 23(13):2586-2596.
3.Wei Wanli, Wang Xiantao, Kusiak JohnW. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection [J]. J Biol Chem,2002, 277(20):17649-17656.
4. Griffin RJ, Moloney A, Kelliher M,et al.Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology [J].J Neurochem, 2005, 93(1):105-117.
5. Annika Rickle, Nenad Bogdanovic, Inga Volkmann,et al. PTEN levels in Alzheimer's disease medial temporal cortex[J]. Neurochem Int, 2006, 48(2):114-123.
6. 刘荣芳，许文芳，许盈，等. 冈田酸诱导SH-SY5Y细胞后tau蛋白磷酸化与PTEN蛋白水平的变化[J].福建医科大学学报, 2006, 41(1):17-20.
7.张章，俞昌喜. 褪黑素对侧脑室注射氯化铝致小鼠学习记忆障碍的改善作用及其机制[J].药学学报, 2002, 37(9): 682-686.
8.张均田，管林初.学习、记忆实验法和记忆障碍动物模型[M]//张均田.现代药理实验方法.上册.第一版.北京:北京医科大学中国协和医科大学联合出版社，1998:1020-1029.
9. 张章，俞昌喜，高凌云，等. 褪黑素对铝毒性痴呆小鼠海马组织病理变化的影响[J].中华老年医学杂志, 2003, 22(9): 559-560.
10. James L. McGaugh, Philip W. Landfield. Delayed development of amnesia following electroconvulsive shock [J].Physiol & behav, 1970, 5(10):1109-1113.
11. Guntern R, Bouras C, Hof PR,et al.An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease[J]. Experientia, 1992, 48(1): 8-10.
12. Gillian Hamilton, Farzana Samedi, Jo Knight,et al. Polymorphisms in the phosphate and tensin homolog gene are not associated with late-onset Alzheimer’s disease [J]. Neurosci Lett, 2006, 401:77–80.
13. Yuma Sonoda, Hideyuki Mukai, Kazuhiko Matsuo,et al. Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles [J]. Neurosci Lett, 2010, 471:20–24.
Arne Gericke, Mary Munson, Alonzo H. Ross. Regulation of the PTEN phosphatase [J]. Gene, 2006, 374:1-9.

[1]	XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8.
[2]	SUN Li-cong, ZHANG Dan-shen.Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37.
[3]	WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si.Current Situation and Prospect of Alzeimer’s Disease Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42.
[4]	ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia.Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64.
[5]	HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64.
[6]	ZHANG Hao-ting, SONG Gui-qin, CUI Ruo-tong, HAO Min, WANG Wen-dong.Mining Target Genes of Alzheimer’s Disease Associated with Biological Clock by Bioinformatics Analysis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 1-7.
[7]	YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong.Research Progress in Drug Treatment of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53.
[8]	ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46.
[9]	ZHANG Qun-feng，HE Huan-ying，LIAO Yun-hao，WANG Guo-qing.The Effects of Maternal Chlorpyrifos Exposure on the Expression of COX2，CREB and BDNF in Hippocampus of Offspring Mice[J]. Acta Neuropharmacologica, 2019, 9(6): 1-5.
[10]	WU Chun-yang，MA Jia-cheng，ZHANG Nan，et al.Batch Determination of Amino Acid Neurotransmitters and Taurine in Mouse Cortex and Hippocampus by Amino Acid Analyzer[J]. Acta Neuropharmacologica, 2019, 9(5): 10-16.
[11]	YANG-Lin，AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64.
[12]	ZHANG Shuai，AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20.
[13]	王奇.Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease[J]. Acta Neuropharmacologica, 2018, 8(5): 71-72.
[14]	ZHOU Yu.Selective deletion of dnmts in excitatory neurons impairs recognition memory and synaptic function in hippocampal network of adult mice[J]. Acta Neuropharmacologica, 2018, 8(5): 84-85.
[15]	CUI Su-ying, SONG Jin-zhi, CUI Xiang-yu, HU Xiao, DING Hui, YE Hui, ZHANG Yong-he.Intracerebroventricular Streptozocin-induced Alzheimer’s Disease-like Sleep Disorders: Role of the GABAergic System in the Parabrachial Complex[J]. Acta Neuropharmacologica, 2018, 8(5): 96-97.